stem cell articles:

Screen Shot 2021-07-17 at 11.47.11 AM

Wound healing is a highly orchestrated physiological process consisting of a complex events, and scarless wound healing is highly desired for the development and application in clinical medicine. Recently, we have demonstrated that human amniotic epithelial cells (hAECs) promoted wound healing and inhibited scar formation through a paracrine mechanism. However, exosomes (Exo) are one of the most important paracrine factors.

Dr. X Talks Stem Cell Research

Watch Doc X’s latest interview with Invitrx on groundbreaking Stem Cell Therapy research. #dentistry #oralhealth #teeth #dentalcare #dental #dentalhealth #oralcare #dentalclinic

Screen Shot 2021-07-17 at 11.50.40 AM

Severe psoriasis, a chronic inflammatory skin disease is increasingly being effectively managed by targeted immunotherapy but long-term immunotherapy poses health risk and loss of response. Therefore, there is a need for alternative therapy strategies. Mesenchymal stem/stromal cell (MSC) exosomes are widely known for their potent immunomodulatory properties. Here we investigated if topically applied MSC exosomes could alleviate psoriasis-associated inflammation.

Emerging role of Exosomes in Craniofacial and Dental Applications

Exosomes, a specific subgroup of extracellular vesicles that are secreted by cells, have been recognized as important mediators of intercellular communication. They participate in a diverse range of physiological and pathological processes. Given the capability of exosomes to carry molecular cargos and transfer bioactive components, exosome-based disease diagnosis and therapeutics have been extensively studied over the past few decades. Herein, we highlight the emerging applications of exosomes.

Topical Application of Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells in Combinat

The topical application of exosomes secreted by mesenchymal stem cells (MSC-Exos) on the skin is a very new and interesting topic in the medical field. In this study, we aimed to investigate whether marine sponge Haliclona sp. spicules (SHSs) could effectively enhance the skin delivery of human umbilical cord-derived MSC-Exos (hucMSC-Exos), and further evaluate the topical application of hucMSC-Exos combined with SHSs in rejuvenating photoaged mouse skin.

BAYLX,INC. Announced Clearance of COVID-19 IND From US FDA For Cord Mesenchymal Stem Cells

Baylx, Inc. (Baylx), a clinical-stage stem cell biopharmaceutical company focused on developing living stem cell products to address unmet medical needs, today announced that the U.S. Food and Drug Administration (FDA) cleared Baylx's Investigational New Drug (IND) application for BX-U001, a fresh, non-frozen human umbilical cord tissue mesenchymal stem cells (hUC-MSC) productin patients with COVID-19.

Caffeine Augments The Instruction of Anti-Inflammatory Macrophages by The Conditioned Medium of Mese

Mesenchymal stem cells (MSCs) have been shown to produce adenosine, express adenosine receptors, and communicate with macrophages and other cells. However, there is no information about the role of caffeine, as a popular drink and adenosine antagonist, on the crosstalk between MSCs and immune cells. The aim of the current study is to evaluate the effects of the conditioned medium of MSCs treated with caffeine on macrophages.

Emerging functions and clinical applications of exosomes in Human Oral Diseases

Exosomes are cell-derived membranous vesicles of endosomal origin secreted by all type of cells and present in various body fuids. Exosomes are enriched in peptides, lipids, and nucleic acids, emerging as vital modulators in intercellular communication. Exosomes are increasingly being evaluated as biomarkers for diagnosis and prognosis of diseases, because the constituents of exosomes could be reprogrammed depending on the states of diseases. These features also make exosomes a research hotspot.

FDA clears IND application for cell therapy to treat radiotherapy-induced dry mouth

The FDA cleared an investigational new drug application for a mesenchymal stromal cell therapy to treat radiotherapy-induced xerostomia, also known as dry mouth.